Fosun Technology (000973.SZ): Progressing with partner to establish a lithium sulfide project company, but the company's shareholding is only 5%.

The Zhixin Financial News APP reported that Fosun Pharma (000973.SZ) announced that the company is advancing its polyimide-nylon film project. The investment and construction period of the polyimide-nylon film project is relatively long, and factors such as resource inputs, construction environment, and approval procedures may affect the project construction process, leading to the risk of not being able to complete the project on time. After the investment and construction of the polyimide-nylon film project, the company will face operational risks in terms of macroeconomics, industry policies, technological updates, and market competition, which may prevent the expected investment returns from being realized. In addition, the company and its partners are working on setting up a lithium sulfide project company. The company holds a 5% stake in the project company, which will not be included in the company's consolidated financial statements after its establishment. It is expected that this investment will not have a significant impact on the company's future financial condition and operating results.